U.S. markets closed
  • S&P 500

    4,070.56
    +10.13 (+0.25%)
     
  • Dow 30

    33,978.08
    +28.67 (+0.08%)
     
  • Nasdaq

    11,621.71
    +109.30 (+0.95%)
     
  • Russell 2000

    1,911.46
    +8.39 (+0.44%)
     
  • Crude Oil

    79.38
    -1.63 (-2.01%)
     
  • Gold

    1,943.90
    -2.80 (-0.14%)
     
  • Silver

    23.73
    -0.30 (-1.23%)
     
  • EUR/USD

    1.0874
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    3.5180
    +0.0250 (+0.72%)
     
  • GBP/USD

    1.2395
    -0.0012 (-0.10%)
     
  • USD/JPY

    129.8000
    -0.3530 (-0.27%)
     
  • BTC-USD

    23,231.71
    +167.49 (+0.73%)
     
  • CMC Crypto 200

    526.66
    +9.65 (+1.87%)
     
  • FTSE 100

    7,765.15
    +4.04 (+0.05%)
     
  • Nikkei 225

    27,382.56
    +19.81 (+0.07%)
     

Synopsys Analyst Slashes Price Target By 6% To Be In Line With Peers

  • Wells Fargo analyst Gary Mobley maintains Synopsys Inc (NASDAQ: SNPS) with an Overweight and lowered the price target from $425 to $400.

  • Ahead of Synopsys' October quarter EPS print, he re-rated the stock.

  • He slashed his price target to be more in line with their peers.

  • He believes SNPS should command a similar (or slight premium) valuation to peers as the company's forward-three-year EPS CAGR of ~15% is at or slightly above peers.

  • He believes Synopsys will post a beat-and-raise quarter and guide.

  • While there is some investor concern about Synopsys' China exposure and exposure to the semi-cycle, he still thinks it is an excellent time to be an EDA company, with multiple secular tailwinds driving growth.

  • The tailwinds included fragmentation of the chip design industry and chip design teams taking more significant deals.

  • Price Action: SNPS shares traded lower by 0.37% at $323.62 on the last check Tuesday.

Latest Ratings for SNPS

Date

Firm

Action

From

To

Jan 2022

Keybanc

Maintains

Overweight

Dec 2021

Rosenblatt

Maintains

Buy

Dec 2021

Needham

Maintains

Buy

View More Analyst Ratings for SNPS

View the Latest Analyst Ratings

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.